Farms.com Home   Ag Industry News

Industrial hemp may soon be grown in South Dakota

Bill is now heading to the Senate for review and consideration

By Diego Flammini
Assistant Editor, North American Content
Farms.com

Farmers in South Dakota could soon be legally allowed to grow industrial hemp.

South Dakota’s House of Representatives voted 57-11 in favor of a bill that would allow industrial hemp to be cultivated.

The bill will now head to the Senate for deliberation.

The bill’s main House sponsor, Mike Verchio, says allowing farmers to grow industrial hemp can help with economic development and job creation.

If approved, farmers can apply to the state Department of Agriculture to grow industrial hemp – provided they pass background checks; earlier in February, North Dakota state Agriculture Commissioner Doug Goehring chose three farms to test if industrial hemp can be successfully grown.

For those concerned about hemp’s close link to marijuana, Verchio said the South Dakota bill restricts the amount of THC – the main ingredient responsible for marijuana’s effects.

“Upon meeting the requirements of sections 2 to 6 inclusive, of this Act, any person in this state may plant, grow, harvest, possess, process, sell, and buy industrial hemp (cannabis sativa l.) having no more than three-tenths of one percent tetrahydrocannabinol,” part of the bill reads.

According to the National Conference of State Legislatures, California, Colorado, Connecticut, Delaware, Hawaii, Illinois, Indiana, Kentucky, Maine, Maryland, Michigan, Montana, Nebraska, Nevada, New Hampshire, New York, North Carolina, North Dakota, Oklahoma, Oregon, South Carolina, Tennessee, Utah, Virginia, Vermont, Washington and West Virginia allow for hemp to be grown for either commercial or research use.


Trending Video

Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Video: Finding a Balance of Innovation and Regulation - Dr. Peter Facchini

Regulations help markets and industry exist on level playing fields, keeping consumers safe and innovation from going too far. However, incredibly strict regulations can stunt innovation and cause entire industries to wither away. Dr. Peter James Facchini brings his perspective on how existing regulations have slowed the advancement of medical developments within Canada. Given the international concern of opium poppy’s illicit potential, Health Canada must abide by this global policy. But with modern technology pushing the development of many pharmaceuticals to being grown via fermentation, is it time to reconsider the rules?

Dr. Peter James Facchini leads research into the metabolic biochemistry in opium poppy at the University of Calgary. For more than 30 years, his work has contributed to the increased availability of benzylisoquinoline alkaloid biosynthetic genes to assist in the creation of morphine for pharmaceutical use. Dr. Facchini completed his B.Sc. and Ph.D. in Biological Sciences at the University of Toronto before completing Postdoctoral Fellowships in Biochemistry at the University of Kentucky in 1992 & Université de Montréal in 1995.